Anticoagulant Utilization Pattern

Boehringer Ingelheim

Status: Completed

Conditions: Atrial Fibrillation

Study type: Observational

Funder types: Industry

Identifiers

NCT01847560

1160.177

Details and patient eligibility

About

This study plans to describe utilization patterns for oral anticoagulants over time in patients with non-valvular atrial fibrillation at risk for stroke using electronic claims data from a United States commercial insurance database.

Enrollment: 333,664 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A recorded diagnosis of atrial fibrillation
• Initiation of oral anticoagulant medication
• Congestive Heart Failure, Hypertension, Age > 75, Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack, Vascular Disease, Age 65-74, Sex Category (CHA2DS2-VASc) Score >=1
• At least 18 years of age on the date of anticoagulant initiation

Exclusion criteria

• Patients with missing or ambiguous age or sex information
• Patients with documented evidence of valvular disease
• Patients with less than 12 months enrolment in the UnitedHealth Research Database preceding the first dispensing
• Patients with prior use of any oral anticoagulant

Trial design

333,664 participants in 2 patient groups

Dabigatran

Warfarin or other New Oral Anticoagulant (NOAC)